Marco Strub
Director/Board Member at ZINCX RESOURCES CORP.
Net worth: 47 153 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peeyush Varshney | M | 57 |
MVE Capital Corp.
| 20 years |
| Angela Holowaychuk | F | 41 | 6 years | |
| Stefan Matthews | M | - | 6 years | |
| Debbie Lew | F | 45 |
MVE Capital Corp.
| 18 years |
| John Anderson | M | 60 | 14 years | |
| Tibor Gajdics | M | 65 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 6 years |
| Mervyn Pinto | M | 74 | 18 years | |
| Mark Redcliffe | M | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Michael Darcy | M | - | 5 years | |
| Graeme Hopkins | M | - | 16 years | |
| Praveen Kumar Varshney | M | 59 | 19 years | |
| Xin Fu Hu | M | 60 | 6 years | |
| Daniel Diemers | M | - | 3 years | |
| Deborah Rosati | F | 62 | 4 years | |
| Gregory Sparks | M | 70 | 7 years | |
| Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 years |
| John Thomas | M | 76 | 17 years | |
| Mary L. Campbell | F | - |
Sircon AG
| - |
| Joyce Heinzerling Davis | F | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 years |
| Marty Henning | M | - | 4 years | |
| Kalev Suurkask | M | - | 3 years | |
| Lars Jörgensen | M | - | 4 years | |
| Cyrille Albrecht | M | - | 4 years | |
| David Allen | M | 60 | 3 years | |
| Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 years |
| Brian Bower | M | - | 4 years | |
| Lindsay Forrest | F | - | 3 years | |
| Jesse Halle | M | - | 8 years | |
| Conrad Druzeta | M | - | 5 years | |
| Marc Brühwiler | M | - |
Clarrence AG
 Clarrence AG Investment ManagersFinance Clarrence AG provides investment services. The company is headquartered in Zug, Switzerland. | - |
| Rakesh Patel | M | - | 7 years | |
| Ken MacDonald | M | - | 14 years | |
| Marco Bianchini | M | - |
Clarrence AG
Clarrence AG Investment ManagersFinance Clarrence AG provides investment services. The company is headquartered in Zug, Switzerland. | - |
| Donna Moroney | F | 64 | 5 years | |
| Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hari Babu Varshney | M | 79 | 3 years | |
| Paul Reynolds | M | 60 | 7 years | |
| Tony Barresi | M | - | 3 years | |
| Glen Diduck | M | 70 | 11 years | |
| Simon Moore | M | - | - | |
| Tim Termuende | M | 61 | 9 years | |
| Richard Baker | M | - | 3 years | |
| Jerry D. Chan | M | - | - | |
| Susan Craig | F | - | 5 years | |
| Richard Underhill | M | - | - | |
| Paul R. Brockington | M | - | 4 years | |
| Marcus Kremer | M | 62 |
University of St. Gallen
| 8 years |
| John G. Burges | M | - | - | |
| Brian May | M | 41 | 2 years | |
| Yevgeniy Meshcherekov | M | 47 | 2 years | |
| Chris Naprawa | M | - | 2 years | |
| Thomas J. Humphreys | M | 38 | 3 years | |
| Taras Kulyk | M | - | 1 years | |
| Mark Edward Thompson | M | 52 | 3 years | |
| Joseph Campbell | M | 66 | 5 years | |
| Joseph Chin | M | - | - | |
| John R. Fraser | M | - | 15 years | |
| John Kearney | M | 74 | 16 years | |
| Stefan Schmittmann | M | 67 |
University of St. Gallen
| 10 years |
| Buddy Doyle | M | 62 | 6 years | |
| Michael J. Cella | M | - | 2 years | |
| Henry M. Giegerich | M | 93 | - | |
| Peter A. Wuffli | M | 66 |
University of St. Gallen
| 3 years |
| Darryl Sittler | M | 73 | 6 years | |
| Gregory Johnson | M | 58 | 9 years | |
| Ernst Albert Kenngott Klein | M | 61 |
University of St. Gallen
| 5 years |
| Frédéric de Boer | M | 63 |
University of St. Gallen
| 4 years |
| Matthew Whitcomb | M | - | - | |
| Satoshi Kitahama | M | - | - | |
| Peter Wielgosz | M | - | - | |
| Rich Wheeless | M | - | - | |
| Delphine Forma | F | - | - | |
| Dean Rakic | M | - | - | |
| Jürg A. Hässig | M | - |
University of St. Gallen
| 2 years |
| Hans-Peter Wuest | M | 63 |
University of St. Gallen
| 4 years |
| Allan E. Armitage | M | - | - | |
| Garry Stock | M | 56 | 1 years | |
| Axel P. Lehmann | M | 65 |
University of St. Gallen
| 2 years |
| Gilbert J. B. Probst | M | 73 |
University of St. Gallen
| 3 years |
| Roland Weber | M | 67 |
University of St. Gallen
| 2 years |
| Matthias Daniel Reinhart | M | 64 |
University of St. Gallen
| 4 years |
| Nick Günther Reh | M | 63 |
University of St. Gallen
| 4 years |
| Connie Norman | F | - | - | |
| Markus Willi | M | - |
University of St. Gallen
| 4 years |
| Rudolf Stämpfli | M | 69 |
University of St. Gallen
| 4 years |
| Hans Jebsen | M | 67 |
University of St. Gallen
| 3 years |
| Roland Iff | M | 63 |
University of St. Gallen
| 4 years |
| Hans-Werner Gassner | M | 66 |
University of St. Gallen
| 1 years |
| David Rokoss | M | - | - | |
| Melissa Martensen | F | 45 | 1 years | |
| William Glen Harris | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 71 | 78.02% |
| Switzerland | 20 | 21.98% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marco Strub
- Personal Network
